Patient Guide: Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 68 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT02962414
Status: ACTIVE_NOT_RECRUITING
Condition: Tuberous Sclerosis Complex
Phase: PHASE3

Find a Study Location Near You

This study is available at 68 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Phoenix, Arizona
  • Los Angeles, California
  • Oakland, California
  • • And 65 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily